CT-STARWOOD-HOTELS
Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT) today announced that it has closed on the sale of Hotel Imperial, a Luxury Collection Hotel, Vienna to Al Habtoor Investment - the investment arm of UAE conglomerate Al Habtoor Group for $78.8 million USD. As part of the transaction, all rooms and suites of the iconic hotel will be renovated over the next four years. Hotel Imperial will continue to operate as part of The Luxury Collection brand under a new long-term management agreement.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160215005701/en/
Thomas Mangas, Chief Executive Officer of Starwood Hotels & Resorts Worldwide, Inc. said: “On the heels of exceeding our $800 million asset disposition target in 2015, the sale of Hotel Imperial underscores Starwood’s continued commitment to advancing our asset light strategy to create value for our shareholders. The Hotel Imperial is truly one of Europe’s most spectacular luxury properties and a perennial favorite among our loyal travellers.”
Khalaf Ahmad Al Habtoor, Founder and Chairman, Al Habtoor Group, said: “Hotel Imperial is one of Europe’s most extraordinary luxury hotels and a premium addition to our growing global portfolio. We look forward to making further improvements to this legendary property and continuing to provide exceptional luxury hospitality to the next generation of luxury travellers.”
Hotel Imperial is the fifth Starwood property in the Group’s portfolio of 14 world-class hotels, joining the newly opened The St Regis Dubai, as well as the upcoming W Dubai – Al Habtoor City, The Westin Dubai, Al Habtoor City and The St. Regis Dubai, Al Habtoor Polo Resort and Club.
Simon Turner, President of Global Development for Starwood, added: “This transaction expands our relationship with Al Habtoor Group, and we are thrilled to work closely together with them to ensure the continued success of Hotel Imperial. Starwood remains keenly focused on selling its owned properties to the right long-term partners, and we see strong interest in our remaining assets from a broad array of high-quality investors from around the world.”
Built in 1863 as Prince Philipp of Württemberg’s Viennese residence, Hotel Imperial was transformed into a hotel to accommodate visitors of the 1873 World’s Fair. Situated on the iconic Ringstrasse (Ring Boulevard) in the city’s center, Hotel Imperial occupies a prime location at Kärntner Ring 16. The luxury hotel is next to the legendary Musikverein concert hall and a short walk from attractions such as the Vienna State Opera, Kunsthistorisches Museum and Secession Building.
Michael Wale, President of Starwood for Europe, Africa and Middle East concluded: “We are delighted to extend our relationship with the Al Habtoor family, with whom we are launching Starwood’s largest hospitality project in the Middle East this year. Hotel Imperial was one of the first Luxury Collection hotels and its full restoration together with our partners will reinforce the majestic heritage of this historic hotel as we continue to provide global explorers with indigenous experiences in Vienna.”
The residence of choice for royalty and high society visiting Vienna for more than 140 years, Hotel Imperial features 138 guestrooms including 59 suites. In 2014, the hotel completed a $14 million restoration of its ground floor, which includes the landmark lobby, a signature restaurant, destination bar, Cafe Imperial and Imperial Torte shop, and private event venues spanning more than 4,000 square feet.
About Starwood Hotels & Resorts Worldwide, Inc.
Starwood Hotels & Resorts Worldwide, Inc. is one of the leading hotel and leisure companies in the world with more than 1,270 properties in some 100 countries and over 180,000 employees at its owned and managed properties. Starwood is a fully integrated owner, operator and franchisor of hotels, resorts and residences under the renowned brands: St. Regis ® , The Luxury Collection ® , W ® , Westin ® , Le Méridien ® , Sheraton ® , Tribute Portfolio ™, Four Points ® by Sheraton, Aloft ® , Element ® , along with an expanded partnership with Design Hotels ™ . The Company also boasts one of the industry’s leading loyalty programs, Starwood Preferred Guest (SPG® ). Visit www.starwoodhotels.com for more information and stay connected @starwoodbuzz on Twitter and Instagram and facebook.com/Starwood .
About Al Habtoor Group
Al Habtoor Group, headquartered in the United Arab Emirates (UAE), is one of the region’s largest and most respected conglomerates. Founded in 1970 by Khalaf Ahmad Al Habtoor, the Group has grown in unison with the UAE and today has a diverse portfolio of successful business operating in key sectors of the economy (hospitality, automotive, real estate, education and publishing). The AGH has an unwavering commitment to excellence, which is apparent throughout all its units. Further information on the Al Habtoor Group is available on www.habtoor.com
About Al Habtoor Investment
Al Habtoor Investment (AHI) is the investment arm of UAE conglomerate Al Habtoor Group (AHG). AHI currently owns seven world-class international hotels. AHI (LLC) takes great pride in its international assets and competes on a global scale with many international chains. The portfolio consists of the historic Hotel Imperial, a Luxury Collection Hotel, Vienna, the Hilton London Wembley, two Hilton-branded hotels in Lebanon (Hilton Beirut Habtoor Grand Hotel, Hilton Beirut Metropolitan Palace), one in the United States (President Abraham Lincoln Springfield – a DoubleTree by Hilton Hotel), and two five-star hotels in Hungary (InterContinental Hotel Budapest, The Ritz-Carlton Budapest). For more information about these assets, please visit www.habtoor.com/alhabtoorinvestment
Note: This press release contains forward-looking statements within the meaning of federal securities regulations. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties and other factors that may cause actual results to differ materially from those anticipated at the time the forward-looking statements are made. Further results, performance and achievements may be affected by general economic conditions including the impact of war and terrorist activity, natural disasters, business and financing conditions (including the condition of credit markets in the U.S. and internationally), foreign exchange fluctuations, cyclicality of the real estate (including residential) and the hotel and vacation ownership businesses, operating risks associated with the hotel, vacation ownership and residential businesses, relationships with associates and labor unions, customers and property owners, the impact of the internet reservation channels, our reliance on technology, domestic and international political and geopolitical conditions, competition, governmental and regulatory actions (including the impact of changes in U.S. and foreign tax laws and their interpretation), travelers’ fears of exposure to contagious diseases, risk associated with the level of our indebtedness, risk associated with potential acquisitions and dispositions and the introduction of new brand concepts and other risks and uncertainties. These risks and uncertainties are presented in detail in our filings with the Securities and Exchange Commission.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160215005701/en/
Contact:
Media:
Starwood Hotels & Resorts
Carrie
Bloom, +1-203-964-5755
carrie.bloom@starwoodhotels.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 00:45:00 CEST | Press release
POD1UM-303/InterAACT 2 is the first and largest global Phase 3 trial evaluating a PD-1 inhibitor in combination with chemotherapy for the treatment of patients with advanced SCAC not previously treated with systemic chemotherapy The trial met its primary endpoint; treatment with retifanlimab in combination with platinum-based chemotherapy (carboplatin-paclitaxel) resulted in clinically meaningful improvements in progression-free survival and overall survival In May 2025, the U.S. Food and Drug Administration (FDA) approved Zynyz® (retifanlimab-dlwr) in combination with carboplatin and paclitaxel and as a single agent for the treatment of advanced SCAC; submissions to other global regulatory agencies are also under review Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-base
Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 21:30:00 CEST | Press release
Progress in natural refrigerants, water efficiency and circular economy underscores Güntner’s global impact Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal,
Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 20:45:00 CEST | Press release
Windsurf launches a GPU cluster in Germany, delivering 50% faster performance and secure access to European enterprises. Data residency ensures enterprise repositories stay within the EU, meeting stringent security requirements. Windsurf already supports 100+ European enterprise customers, highlighting strong demand for AI-powered development tools across EMEA. Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of
Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 19:00:00 CEST | Press release
New SDK Integration Simplifies Monetization for Defold Developers Publishing on CrazyGames Ahead of Global Game Jam Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization jou
Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 17:00:00 CEST | Press release
The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom